A research team at the University of Virginia School of Medicine, led by Boris P. Kovatchev, is looking to automate the monitoring of blood glucose levels and insulin for type 1 diabetes patients, essentially creating an artificial pancreas – using a smartphone.
This progress is influenced by the $3.4 million grant from the National Institutes of Health.
A digital glucose monitor in combination with a digital insulin pump will provide real-time communication by using algorithms in conjunction with cloud-based computing. The project’s servers will facilitate high quality data collection in conjunction with on-demand telemedicine services.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
The developers intend for it to monitor blood-sugar levels instantly and report data to a remote-monitoring site and link the user with assistance using telemedicine as needed.
This would prevent patients from needing to prick their fingers to check glucose levels.